-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Concert Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2013 to 2021.
- Concert Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 49.7M shares, a 45.9% increase year-over-year.
- Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 34.4M shares, a 10.3% increase from 2020.
- Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 31.2M shares.
- Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 23.4M shares, a 0.31% decline from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)